Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120,538,577
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
586,328
-
Shares change
-
+226,258
-
Total reported value, excl. options
-
$3,365,000
-
Value change
-
+$1,292,854
-
Number of buys
-
7
-
Number of sells
-
-1
-
Price
-
$5.74
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) as of Q1 2021
8 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value as of Q1 2021.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 586,328 shares
of 120,538,577 outstanding shares and own 0.49% of the company stock.
Largest 8 shareholders include SABBY MANAGEMENT, LLC (418,437 shares), EMC Capital Management (75,835 shares), CITADEL ADVISORS LLC (36,652 shares), MILLENNIUM MANAGEMENT LLC (35,310 shares), DAVENPORT & Co LLC (15,000 shares), WOLVERINE ASSET MANAGEMENT LLC (3,078 shares), Tower Research Capital LLC (TRC) (2,016 shares), and UBS Group AG (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.